A French-Italian survey on the prevalence of isolated varices (C2) and complicated varices (C2+). Results of a multi-centre study conducted by the SFA and the SFP under the auspices of the European Venous Forum.
OBJECTIVE
The advanced CEAP classification allows one to differentiate between isolated varicose veins (C2) and complicated varicose veins (C2, 3 - C2, 3, 4 - C2, 4 or C2, 3, 4, 5 etc) named (C2+).


METHODS
The main objective of this study was to identify when using the advanced classification the prevalence of isolated varicose veins (C2) and complicated varicose veins (C2+) among patients consulting vascular specialists and to compare their symptomatic status and the data issued from the advanced CEAP including also the headings, Anatomy (A), Etiology (E) and Pathophysiology (P).


RESULTS
171 patients were evaluated, 100 in France and 71 in Italy. The prevalence of C2 and C2+ was the same in both countries: 64.4% in France and 63.3% in Italy. Also no difference was found in the prevalence of other descriptors: etiology, anatomy or pathophysiology. The time to complete the advanced form was less than 5 minutes for 65% of the investigators.


CONCLUSIONS
The advanced CEAP is easy to use in daily pratice. We have the same prevalence of patients in France and in Italy, who consulted for isolated varicose veins or associated with other signs of chronic venous disorders.
Cazaubon
M
M
Angiology American Hospital, Paris, France. micazang@noos.fr
Allaert
F A
FA
Lugli
M
M
Buresta
P
P
Gobin
J P
JP
Perrin
M
M
D000328:Adult; D000368:Aged; D000704:Analysis of Variance; D016009:Chi-Square Distribution; D005260:Female; D005602:France / Q000453:epidemiology; D006305:Health Status Indicators; D006306:Health Surveys; D006801:Humans; D007558:Italy / Q000453:epidemiology; D008297:Male; D008875:Middle Aged; D015995:Prevalence; D012017:Referral and Consultation; D012720:Severity of Illness Index; D009626:Terminology as Topic; D014648:Varicose Veins / Q000145:classification / Q000150:complications / Q000175:diagnosis / Q000453:epidemiology*